TY - JOUR
T1 - Rates and correlates of pharmacotherapy-related problems among psychiatric inpatients
T2 - a representative Danish study
AU - Kibsdal, Karina Porsborg
AU - Andersen, Sabina
AU - Gazerani, Parisa
AU - Plet, Hanne
PY - 2020
Y1 - 2020
N2 - Background: Drug related problems (DRPs) occur frequently among psychiatric patients dueto common prescribing errors and complex treatment schedules. Clinical pharmacists (CPs)are thought to play an important role in preventing DRPs and, consequently, to increasing the quality of inpatient care. There is, however, limited information available on DRPs within the psychiatric field in Denmark. The aim of this study was to identify rates and correlatesof pharmacotherapy-related problems among psychiatric inpatients in a Danish psychiatrichospital.Methods: A retrospective descriptive study was conducted by two CPs and data were obtainedfrom the medical records available in two psychiatric wards. Chart-reviews were conducted for the period of June 2015 to February 2017. The analyses focussed on the prevalence of DRP categories, implementation and acceptance rates, and drugs associated with the DRPs. Extracted data were discussed with the wards’ physicians and registered in a DRP-database.Results: In total, 607 medical records were reviewed and, on average, 2.5 DRPs permedication review were found. There was a positive correlation between the numberprescribed drugs and the average number of DRPs. The most frequent categories of DRPswere ‘drug dosage’, ‘inappropriate drug’ and ‘interactions’. The drugs represented mostfrequently in DRPs were olanzapine, quetiapine and pantoprazole. The overall acceptance ratewas 49% with 33% of those implemented clinically.Conclusion: DRPs were commonly observed among psychiatric patients, particularly in thosewith multiple prescriptions, in relation to drugs dosage, inappropriate prescriptions and druginteractions. Particular attention must be paid to olanzapine, quetiapine and pantoprazole.Strategies to minimise DRPs among psychiatric patients are warranted and CPs can play animportant role.
AB - Background: Drug related problems (DRPs) occur frequently among psychiatric patients dueto common prescribing errors and complex treatment schedules. Clinical pharmacists (CPs)are thought to play an important role in preventing DRPs and, consequently, to increasing the quality of inpatient care. There is, however, limited information available on DRPs within the psychiatric field in Denmark. The aim of this study was to identify rates and correlatesof pharmacotherapy-related problems among psychiatric inpatients in a Danish psychiatrichospital.Methods: A retrospective descriptive study was conducted by two CPs and data were obtainedfrom the medical records available in two psychiatric wards. Chart-reviews were conducted for the period of June 2015 to February 2017. The analyses focussed on the prevalence of DRP categories, implementation and acceptance rates, and drugs associated with the DRPs. Extracted data were discussed with the wards’ physicians and registered in a DRP-database.Results: In total, 607 medical records were reviewed and, on average, 2.5 DRPs permedication review were found. There was a positive correlation between the numberprescribed drugs and the average number of DRPs. The most frequent categories of DRPswere ‘drug dosage’, ‘inappropriate drug’ and ‘interactions’. The drugs represented mostfrequently in DRPs were olanzapine, quetiapine and pantoprazole. The overall acceptance ratewas 49% with 33% of those implemented clinically.Conclusion: DRPs were commonly observed among psychiatric patients, particularly in thosewith multiple prescriptions, in relation to drugs dosage, inappropriate prescriptions and druginteractions. Particular attention must be paid to olanzapine, quetiapine and pantoprazole.Strategies to minimise DRPs among psychiatric patients are warranted and CPs can play animportant role.
KW - clinical pharmacy
KW - Denmark
KW - drug related problems
KW - medication review
KW - psychiatry
U2 - 10.1177/2045125320957120
DO - 10.1177/2045125320957120
M3 - Journal article
SN - 2045-1253
VL - 10
JO - Therapeutic Advances in Psychopharmacology
JF - Therapeutic Advances in Psychopharmacology
ER -